Thoratec drops sale of subsidiary to Danaher

07/27/2010 | American City Business Journals

Thoratec has terminated the sale of International Technidyne, which manufactures point-of-care blood tests and skin incision products, to Danaher for $110 million because of disagreements on "certain aspects of ITC's quality system and regulatory filings." Thoratec said it will consider the unit as "held for sale" for its financial results despite the cancellation of the deal.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA